drug
PORT-77
Phase 2updated 6mo agoby GondolaBio LLC
Phase 2community read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying PORT-77
- phase3A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)
- phase1Randomized, Double-Blind, Placebo-Controlled, Single and Multiple Ascending Dose Study of PORT-77 Administered to Healthy Adult Participants
- phase2GATEWAY: A Phase 2a Study of PORT-77 in Adults With Erythropoietic Protoporphyria
News(1)
- BioSpace 40 Under 40 winners Paull, Zhang let patients with rare disease lead the way at BridgeBioBridgeBio has produced two young leaders on BioSpace’s 2026 40 Under 40 list. Morgan Paull and Christine Zhang attribute their early success to the company’s unique hub-and-spoke model and a drive…biospace · 3d ago
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that